We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Newly Augmented Microdispenser System Replaces Five Liquid Handling Instruments

By LabMedica International staff writers
Posted on 13 Apr 2014
Print article
Image: The MultiFlo FX Multi-Mode Dispenser with the BioStack 4, for lidded or unlidded plates (Photo courtesy of Biotek Instruments, Inc.).
Image: The MultiFlo FX Multi-Mode Dispenser with the BioStack 4, for lidded or unlidded plates (Photo courtesy of Biotek Instruments, Inc.).
Upgrades to a highly regarded microdispenser system allows the instrument fo replace up to five separate liquid handlers, saving operator time and instrumentation costs

The new BioTek (Winooski, VT, USA) MultiFlo FX Microplate Dispenser is now available with optional RAD (Random Access Dispense) technology to further extend its application range and flexibility. RAD technology offers single-channel dispensing to random individual microplate wells along with rapid reagent dispensing into large volume wells of 6- to 24-well microplates. MultiFlo FX can also be separately configured with an optional wash module for 6- to 384-well plates.
The Multiflo FX accommodates microplate types ranging from 6- to 1536-wells, and dispenses volumes of from one to three microliters accurately and precisely. BioTek's proprietary angled dispensing ensures compatibility with all dispense protocols including media exchanges with loosely adherent cell monolayers. For assays requiring minimum reagent usage, the MultiFlo's prime volume is less than one milliliter. A built-in priming trough is designed to allow both recovery of reagents or to send primed reagent directly to waste.

MultiFlo FX was especially designed for sensitive cell-based assays, ELISAs, and bead-based assays, with angled dispense tips and flexible flow rates to maintain cell integrity.

Due to its small footprint and base height of less than 20.3 cm, the MultiFlo FX readily fits on any laboratory bench or robotic system. It is easily integrated with the BioTek BioStack Microplate Stacker, allowing up to 75 plates to be dispensed automatically. Simplified programming via intuitive on-board software and a color touch screen display enable control of dispense patterns, and two integrated USB ports provide convenient file transfer and storage options.

“Microplate-based bulk dispensing can be complex, especially in an automated system,” said Jason Greene, BioTek product manager. “We specifically designed MultiFlo FX to streamline this process, providing more value through multitasking, and time savings.”

Related Links:
BioTek


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more